COMMUNICATION
News & Press Release
Neurobiogen, a candidate for new drugs for Alzheimer's, Phase 1 Clinical Treatment.
- DATE : 2022-03-03
- VIEWS : 2812
FILES
- Add(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
- Tel+82-70-4018-8009
- Fax+82-02-3486-2613
- E-mailneuro_reply@neurobiogen.com
FAMILY SITE
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved